Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Caribou Biosciences, Inc.

< Previous 1 2 Next >
News headline image
Caribou Biosciences Reports Third Quarter 2026 Financial Results
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Announces Presentations at the 2026 American Society of Hematology (ASH) Annual Meeting
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences to Evaluate Strategic Alternatives
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences to Participate in Upcoming Investor Conferences
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT® and CIBMTR®
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences to Participate in Upcoming Investor Conferences
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
News headline image
Caribou Biosciences to Participate in Upcoming Investor Conferences
From Caribou Biosciences, Inc.
Via GlobeNewswire
Tickers CRBU
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.